COVID-19 and thromboembolic disease

Friday, July 9, 2021
12. COVID-19, 1-hour Oral Session
S56 8:30 AM > 9:30 AM COVID-19 and thromboembolic disease 12. COVID-19

8:30 AM 3161 Thrombosis pathways in COVID-19 versus influenza-associated acute respiratory distress syndrome (ARDS): a targeted proteomics approach > E. Emma RADEMAKER (Utrecht) 8:40 AM 2857 Venous thromboembolic disease and D-dimer in non-critically ill patients with COVID-19 pneumonia > J. Júlia SELLARÈS-NADAL (Matadepera, Barcelona) 8:50 AM 989 Increased incidence of secondary infections in COVID-19 patients with thrombotic complications > M. Marco RIPA (Milano) 9:00 AM 1038 Early treatment with low-molecular-weight heparin reduces mortality rate of SARS-CoV-2 patients > A. Andrea DE VITO (Sassari) 9:10 AM 1085 Pulmonary embolism in COVID-19 patients: incidence and impact prognosis > M. Mabrouk BAHLOUL (Sfax) 9:20 AM INT16 Q&A/Discussion

Copyright © key4events - All rights reserved